Cereno Scientific strengthens its clinical expertise, recruits top expert as Scientific Advisor
Cereno Scientific today announced that the company is strengthening its clinical expertise by recruiting Dr. Raymond L. Benza, Professor of Medicine and Director, Division of Cardiovascular Medicine, at the Ohio State University Wexner Medical Center in Columbus, USA, as Scientific Advisor to the company.Earlier this March, Cereno Scientific was granted Orphan Drug Designation, by the U.S. Food and Drug Administration (FDA) for the company’s lead compound CS1 to treat the rare disease Pulmonary Arterial Hypertension (PAH), which is a form of high blood pressure in the lungs where the